Presented by:
William G. Kaelin, Jr., M.D.
Investigator, Howard Hughes Medical Institute Professor
Department of Medicine, Dana-Farber Cancer Institute Harvard Medical School

Dr. Kaelin's laboratory studies tumor suppressor genes and the normal functions of the proteins they encode. The long-term goal of their work is to lay the foundation for the development of new anticancer therapies based on the functions of specific tumor suppressor proteins. Such as, it may be possible to develop a drug that mimics the behavior of a certain tumor suppressor protein, or to design strategies for killing only those cells in which a particular tumor suppressor protein has been inactivated, thus sparing normal cells.

Light lunch served

Sponsored by the JCCC Genitourinary Oncology Program Area